Insomnia News and Research

Latest Insomnia News and Research

Chronic insomnia can lead to anxiety and depression

Everyone has an occasional night of bad sleep. For most people, insomnia lasts only a few days and goes away without treatment.

4 Jul 2007

1 teenager in 10 uses prescription drugs for nonmedical purposes

Caregivers have been prescribing psychotropic medication for adolescents in increasing numbers.

27 Jun 2007

Abuse of prescription drugs

Increasingly, drug abusers are getting their next fix from their medicine cabinets, instead of from drug dealers.

26 Jun 2007

Imagery rehearsal therapy helps insomniacs

In a study that insomniacs may find welcoming, imagery rehearsal therapy (IRT) has been shown to subjectively improve their ability to get a good night's sleep, according to research presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

17 Jun 2007

Cognitive behavioral therapy workshops effective at getting men to seek help for insomnia

Despite the positive results that it brings in the treatment of insomnia, access to cognitive behavioral therapy (CBT) has been difficult given the limited awareness of CBT services amongst referrers such as primary care providers.

17 Jun 2007

Sleep disorders common among police officers

Sleep disorders are common, costly and treatable, but often remain undiagnosed and untreated.

16 Jun 2007

Link between restless legs syndrome and hypertension

An international team of researchers, led by Emory University clinician scientists, has found evidence that people suffering from moderate to severe cases of restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.

15 Jun 2007

Neurocrine Biosciences announces resubmission of NDA for Indiplon capsules

Neurocrine Biosciences, Inc. has announced that they have resubmitted its New Drug Application (NDA) for indiplon 5 mg and 10 mg capsules for the treatment of insomnia in both adult and elderly patients to the U.S. Food and Drug Administration (FDA).

14 Jun 2007

Health-care costs higher for insomniacs

Research presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS) finds that the health care costs of patients with insomnia are higher than for those without insomnia.

14 Jun 2007

Anticonvulsant medication gabapentin effective for fibromyalgia pain

New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.

14 Jun 2007

Catastrophic events affect the quality and the quantity of a person's sleep

A significant disruption of day-to-day life can take place in those areas affected by a natural disaster.

14 Jun 2007

First comprehensive description of sleep and wake patterns of cancer patients using continuous polysomnography

Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.

14 Jun 2007

FDA decision over new obesity drug hangs in the balance

The Food and Drug Administration (FDA) in the United States appears to be holding back on it's decision to grant approval for a weight loss drug.

11 Jun 2007

Wide range of sleep-related disorders associated with abnormal sexual behaviors, experiences

A paper published in the June 1st issue of the journal SLEEP is the first literature review and formal classification of a wide range of documented sleep-related disorders associated with abnormal sexual behaviors and experiences.

3 Jun 2007

Daytrana provides significant effectiveness in both boys and girls with ADHD

Shire plc has announced that DAYTRANA (methylphenidate transdermal system), its Attention Deficit Hyperactivity Disorder (ADHD) patch, had significant efficacy in reducing the symptoms of ADHD in both male and female children aged 6 to 12 years, according to clinical trial results reported at the American Psychiatric Association (APA) annual meeting in San Diego.

24 May 2007